Good thing ...We have $ 11M in the bank and another Baxter tranche pending (Interim), and reduced cash outflow on iDialco...and last but not least - the unlimited deep pockets & patience of the FA80 ! (not to mention insider participation in financings (see Bihl/Stevens), and the unending patience of Toray and Birch Hill)
That way we can keep the CCdoubleA peeps at bay.
They all must be eyeing the prize - that $ 2 B USD + opportunity (post FDA), with no competition (i.e no competing NA Trials), a "confirmatory 3 b Trial" that is "exceeding expectations", and the fact that it's 1st and goal to go...after a long haul.
MM